Latest Insights on INDA
Sanofi’s mRNA Play, The SolarEdge Of Greatness & Slinging Spiritual Opium August 3, 2021 Great Stuff Do You Know The Way To Sanofi? Great Ones, the future of health care isn’t in the future … it’s already here. And we can thank COVID-19 for its early arrival. I’m talking about mRNA technology. You know … messenger ribonucleic acid? Did y’all just not take biology in high school? Here’s a quick refresher. […]
Lost In The Amazon, Robinhood’s Sherwood Shakedown & LendingClubbing July 30, 2021 Great Stuff Friday Four Play: The “Captain Obvious” Edition Riddle me this, Great Ones… If a company benefits greatly from a once-in-a-lifetime event, should you expect those benefits to continue beyond the event? The answer, which we all know, is “No.” No, you shouldn’t. I mean, the answer is in the question itself: “once in a lifetime.” […]
Hunting Crypto Wabbits, Hare-Brained Blockchain & What’s Up, Teladoc? July 29, 2021 Great Stuff Crypto FUD Mucking It’s time to break out your Great Stuff decoder rings! No, it’s not time to drink more Ovaltine. It’s time for Reader Feedback! And where we’re going, we’re gonna need decoder rings, Great Ones. I’m talking stablecoins, FUD, FOMO, hodling and more! What is that … Elvish? It’s like a whole other […]
Apple Bottom Dreams, AMD Boots With The Fur July 28, 2021 Great Stuff My Tech Summer (Shove It … Intel) Hey you, Intel (Nasdaq: ). Tell me when it’s over… Hey you, Advanced Micro Devices (Nasdaq: ). Guide me to shelter ‘cause I’m through when the nanometers hit the fan … and it’s summer. Shove it. Shove it. Shove it … Intel! Deftones, anyone? Anyone? Bueller? I’ll tell […]
Clarifying Crypto, Tesla’s Self-Driven Debate & Intel’s Shifting Goal Posts July 27, 2021 Great Stuff Tales From The Crypto Keeper Great Ones, every now and then, we run into some … let’s say “gems” … in the financial media. Little nuggets of nonsense, some ill-informed info that’s inflammatory enough to end up as our Anti-Quote of the Week. I just wanted to preface this junk before we dive in — […]





